suppressor T cell

(redirected from suppressor cell)
Also found in: Dictionary.

suppressor T cell

n.
A T cell that reduces or suppresses the immune response of B cells or of other T cells to an antigen.

suppressor T cell

See T cell.

suppressor T cell

A subpopulation of regulatory T lymphocytes that develop in the thymus gland, that slows or stops a specific immune response.
See also: cell
References in periodicals archive ?
Lutz, "Myeloid-derived suppressor cell activation by combined LPS and IFN-[gamma] treatment impairs DC development," European Journal of Immunology, vol.
In this group, the antihistamine also reversed the enhanced tumor growth normally seen with myeloid derived suppressor cell injection.
Mitogen responsiveness and suppressor cell function in multiple sclerosis: influence of age and disease activity.
Most studies report a disproportionate proliferation of the suppressor cell (CD8) population that leads to a lowering of the helper-suppressor ratio (CD4:CD8 ratio).
Our patented AMX-513 combination therapy enables the immune system to attack cancer by regulating myeloid-derived suppressor cells.
The reports detail a newfound importancefor immune system suppressor cells in controlling human immunodeficiency virus (HIV), a suggestion that the virus sparks an autoimmune attack, and the discovery of a small protein that blocks the virus's binding site on its target cells.
Activation of the LXR-ApoE pathway by RGX-104 stimulates the innate immune response in cancer via depletion of myeloid-derived suppressor cells and activation of dendritic cells, leading to stimulation of T cells and anti-tumor immunity.
Among the topics are Paul Ehrlich and the early history of granulocytes, the regulatory function of eosinophils, toll-like receptor signaling and its inducible proteins, myeloid cell phenotypes in susceptibility and resistance to helminth parasite infections, and tumor-induced myeloid-derived suppressor cells.
The therapy blocks suppressor cells and activates anti-tumour effector cells, transforming the microenvironment of the tumour.
Armed with this knowledge, the team set to reverse this process and boost the anti-cancer fighting properties of the immune system, using a cancer vaccine called TroVax, to train the immune system to better recognise tumours while simultaneously removing the problematic immune suppressor cells.
Tumours have the particularity of secreting molecules that allow the recruitment and/or generation of suppressor cells that prevent the immune system from eliminating tumour cells.
NantOmics and NantWork's Augmented Intelligence platforms of unsupervised machine learning and machine vision will be integrated into the OptraSCAN pathology devices to establish state of the art intelligent pathology diagnostic tools in this era of immunotherapy in cancer, enabling the 2D and 3D identification of immune effector and suppressor cells.